
Scientific Games announced on Wednesday, October 27, it would sell its global lottery business to Canadian investment company Brookfield for US$6.05 billion, reported Reuters.
The Las Vegas-based slot machine maker has been trimming down its business after ratcheting up US$8.2 billion in net debt as of June 30. Last month, it sold its sports betting division, OpenBet, to Endeavor Group for US$1.2 billion in cash and stock.
The deal with the flagship unit of Brookfield Asset Management will consist of about US$5.83 billion in cash and an additional payment of up to US$225 million based on meeting certain profitability targets in 2022 and 2023.
Reuters had earlier reported that the company was in talks to potentially list the lottery business in Australia, but those plans will now be shelved because of the deal.
Scientific Games had a net debt leverage ratio, an important gauge of a company’s financial health, of 7.2 times at the end of June, down from 10.5 times at the beginning of the year.
Analysts from Jefferies wrote in a note that they saw the “outcome incrementally favorably,” as the company would get 100% of the net proceeds at closing, and expected leverage to come down imminently.
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Trump Administration Steps Up Pressure On EU Digital Laws
May 18, 2025 by
CPI
Elton John Slams UK Government’s AI Copyright Plan as ‘Theft’
May 18, 2025 by
CPI
Anthropic’s Legal Team Blames AI “Hallucination” for Citation Error in Copyright Lawsuit
May 18, 2025 by
CPI
Intel Challenges €376 Million EU Antitrust Fine in Ongoing Legal Battle
May 18, 2025 by
CPI
FTC Chairman Highlights Fiscal Responsibility and Consumer Protection in House Testimony
May 18, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas